NZ's AFT Pharmaceuticals rises most in six months on upbeat FY earnings, forecast

AFT Pharmaceuticals

20/05/2026 23:52

** Shares of AFT Pharmaceuticals AFT.NZ rise 7.6% to NZ$3.8, on track for best day since November 21 if gains hold

** Stock hits highest level since May 12

** Pharmaceutical firm reports 24% rise in FY net profit after tax to NZ$14.1 million ($8.27 million), operating revenue up 22% at NZ$254.7 million

** Targets NZ$300 million plus revenue for FY27

** Sees FY27 operating profit between NZ$28 million to NZ$32 million vs FY26 operating profit of NZ$24.4 million

** Declares dividend of 2.5 New Zealand cents per share, up from last year's 1.8 NZ cents per share

** Stock up 12.4% YTD

($1 = 1.7042 New Zealand dollars)

 (Reporting by Jasmeen Ara Shaikh in Bengaluru)

 ((Jasmeenaraislam.Shaikh@thomsonreuters.com;))